Browse Category

NASDAQ:ALMS News 6 December 2025 - 2 February 2026

Alumis stock jumps 129% after Phase 3 psoriasis data; ALMS hits new 52-week high

Alumis stock jumps 129% after Phase 3 psoriasis data; ALMS hits new 52-week high

Alumis shares surged 129% Tuesday after its psoriasis pill, envudeucitinib, met all main goals in Phase 3 trials. About 65% of patients reached PASI 90 and over 40% achieved complete clearance at week 24. The company reported no new safety concerns and plans to file for FDA approval in the second half of 2026. Traders are watching durability and safety data.
Biggest Stock Gainers Today (December 5, 2025): TGL, SMX, WHLR, DBRG, TORO, PRAX and RBRK Lead a Volatile Session

Biggest Stock Gainers Today (December 5, 2025): TGL, SMX, WHLR, DBRG, TORO, PRAX and RBRK Lead a Volatile Session

The U.S. stock market logged another upbeat session on Friday, December 5, 2025, with the S&P 500, Nasdaq 100 and Dow all edging higher. But beneath the index-level moves, a cluster of highly volatile small caps, high‑growth tech names and a few mid‑caps stole the show with spectacular double‑ and even triple‑digit gains. StockAnalysis+1 Below is a breakdown of the biggest stock gainers today, why they moved, and what recent forecasts and analyst commentary suggest about their outlooks. All data and price moves refer to the U.S. session on December 5, 2025, unless otherwise noted. Top 10 Biggest U.S. Stock Gainers Today (By

Stock Market Today

SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

7 February 2026
SAP SE closed at 171.22 euros on Xetra Friday, up 0.43%, after disclosing its treasury shares rose above 5% of capital, reaching 61,737,035 shares. The increase follows the launch of a buyback plan worth up to 2.6 billion euros through July 2026. SAP’s U.S. shares finished at $203.34. Investors await SAP’s Integrated Report on Feb. 26 and next results on April 23.
L’Oreal share price slips into weekend as OR.PA heads for annual results test

L’Oreal share price slips into weekend as OR.PA heads for annual results test

7 February 2026
L’Oréal shares closed at 394.05 euros in Paris on Friday, down 0.16%, marking a second straight session of losses. The company will release its 2025 annual results after markets close on Feb. 12, with a financial meeting set for Feb. 13. About 319,000 shares traded Friday in a range between 385.70 and 395.10 euros. The STOXX 600 rose 0.9% to 617.12 points.
Go toTop